Safety profile of extended-release Niacin/Laropiprant in patients with dyslipiclemia

被引：0
|
作者：
McKenney, James
Bays, Harold
Koren, Michael J.
Ballantyne, Christie
Maccubbin, Darbie
Mitchel, Yale
Betteridge, Abigaile
Kuznetsova, Olga
Sapre, Aditi
Sisk, Christine McCrary
Paolini, John F.
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
[2] Merck Res Labs, Rahway, NJ USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2008年 / 51卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A334 / A334
页数：1
相关论文
共 50 条
  • [1] SAFETY PROFILE OF EXTENDED-RELEASE NIACIN/LAROPIPRANT IN PATIENTS WITH DYSLIPIDEMIA
    McKenney, J.
    Bays, H.
    Koren, M.
    Ballantyne, C.
    Maccubbin, D.
    Mitchel, Y.
    Betteridge, A.
    Kuznetsova, O.
    Sapre, A.
    Sisk, C.
    Paolini, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 194 - 195
  • [2] Safety of extended-release niacin/laropiprant in patients with dyslipidemia
    McKenney, James
    Bays, Harold
    Koren, Michael
    Ballantyne, Christie M.
    Paolini, John F.
    Mitchel, Yale
    Betteridge, Abigaile
    Kuznetsova, Olga
    Sapre, Aditi
    Sisk, Christine McCrary
    Maccubbin, Darbie
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (02) : 105 - 112
  • [3] Safety and tolerability of extended-release niacin with laropiprant
    Yadav, Rahul
    Kwok, See
    Ammori, Basil J.
    Issa, Basil
    Soran, Handrean
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (01) : 151 - 159
  • [4] Extended-Release Niacin (Nicotinic Acid)/Laropiprant
    Caroline M. Perry
    Drugs, 2009, 69 : 1665 - 1679
  • [5] Extended-release niacin and laropiprant in the management of dyslipidemias
    Farnier, Michel
    CLINICAL LIPIDOLOGY, 2010, 5 (06) : 783 - 791
  • [6] Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety
    Yadav, Rahul
    France, Michael
    Younis, Naveed
    Hama, Salam
    Ammori, Basil J.
    Kwok, See
    Soran, Handrean
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (09) : 1345 - 1362
  • [7] Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease
    Maccubbin, Dorbie
    Koren, Michael J.
    Davidson, Michael
    Gavish, Dov
    Pasternak, Richard C.
    Macdonell, Geraldine
    Mallick, Madhuja
    Sisk, Christine McCrary
    Paolini, John F.
    Mitchel, Yale
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (01): : 74 - 81
  • [8] Effects of Extended-Release Niacin and Extended-Release Niacin/Laropiprant on the Pharmacokinetics of Simvastatin in Healthy Subjects
    Lauring, Brett
    Dishy, Victor
    De Kam, Pieter-Jan
    Crumley, Tami
    Wenning, Larissa
    Liu, Fang
    Sisk, Christine
    Wagner, John
    Lai, Eseng
    AMERICAN JOURNAL OF THERAPEUTICS, 2015, 22 (05) : 367 - 376
  • [9] Tredaptive((R)) : extended-release niacin with laropiprant
    van Schoor, Jacky
    SA PHARMACEUTICAL JOURNAL, 2012, 79 (09) : 52 - 53
  • [10] Extended-Release Niacin (Nicotinic Acid)/Laropiprant
    Perry, Caroline M.
    DRUGS, 2009, 69 (12) : 1665 - 1679
12345